Streetbeat News

Earnings

AMZN

Amazon is expected to announce strong Q2 earnings, with BofA Securities' analyst Justin Post forecasting $149 billion in revenue and 18% growth in AWS. Despite a positive Q2 outlook, caution is advised for Q3 profit guidance due to high expectations and rising freight costs. Post maintains a Buy rating with a $220 price target.

Portfolio Pulse from Surbhi Jain

July 26, 2024 | 7:54 pm

COUR

IBM

MSFT

Coursera, Inc. (NYSE:COUR) shares surged after reporting better-than-expected Q2 earnings and sales. The company also surpassed 2 million enrollments in its generative AI catalog and launched new Professional Certificates with industry leaders like Google Cloud, IBM, Meta Platforms, and Microsoft. Multiple analysts reiterated positive ratings, while Goldman Sachs maintained a Sell rating but lowered its price target.

Portfolio Pulse from Vaishali Prayag

July 26, 2024 | 7:27 pm

BHRB

Burke & Herbert Financial shares are trading higher following the release of their Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 7:26 pm

SBUX

Whales have shown a bullish stance on Starbucks (NASDAQ:SBUX) with significant options activity. 50% of trades were bullish, 40% bearish, with a price window of $50 to $80. Analysts have mixed ratings, with price targets ranging from $77 to $98.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 7:16 pm

NVO

Unusual options activity has been observed for Novo Nordisk (NYSE:NVO) with a split sentiment of 42% bullish and 52% bearish. A total of 21 uncommon options trades were spotted, with significant amounts in both puts and calls. The stock is currently trading at $127.34, down by 0.41%, and is approaching oversold territory according to RSI readings. The anticipated earnings release is in 12 days.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 7:01 pm

IWM

Small-cap stocks have experienced their strongest three-week rally since August 2022, driven by investor optimism towards interest rate-sensitive industries and expectations of Federal Reserve rate cuts. The iShares Russell 2000 ETF (NYSE:IWM) saw significant inflows in July, reflecting confidence in a solid economic backdrop.

Portfolio Pulse from Piero Cingari

July 26, 2024 | 6:55 pm

ABBV

AbbVie Inc. (NYSE:ABBV) reported strong Q2 earnings, beating both EPS and revenue expectations. Analysts from Cantor Fitzgerald, Truist Securities, and Goldman Sachs have reiterated their positive ratings and increased price targets, citing AbbVie's diversified portfolio and long-term growth potential. Despite some challenges in the aesthetics sector, the company is set for growth driven by key products like Skyrizi and Rinvoq.

Portfolio Pulse from Vandana Singh

July 26, 2024 | 6:54 pm

SKX

Wedbush analyst Tom Nikic reiterated an Outperform rating on Skechers U.S.A., Inc. (NYSE:SKX), raising the price forecast to $79 from $76. Despite missing earnings estimates, the company showed strong wholesale and European growth, leading to raised FY sales/EPS guidance. However, U.S. DTC and China slowed significantly.

Portfolio Pulse from Nabaparna Bhattacharya

July 26, 2024 | 6:35 pm

BFI

COUR

DXCM

MMM

NBY

NMHI

WINT

U.S. stocks traded higher with the S&P 500 gaining over 1%. 3M Company shares surged 21% after strong Q2 results and raised FY24 EPS outlook. Windtree Therapeutics, BurgerFi International, and Coursera saw significant gains, while NovaBay Pharmaceuticals, DexCom, and Nature’s Miracle Holding experienced sharp declines.

Portfolio Pulse from Avi Kapoor

July 26, 2024 | 6:33 pm

FCX

Recent options activity for Freeport-McMoRan (NYSE:FCX) shows a bearish sentiment among major investors, with 59% of trades being bearish. The stock is currently trading at $44.88, up 0.79%, and analysts have mixed ratings with price targets ranging from $53 to $60.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 6:31 pm